Von Hippel Lindau (VHL) (NM_000551) Human Recombinant Protein
CAT#: TP316151
Recombinant protein of human von Hippel-Lindau tumor suppressor (VHL), transcript variant 1
Specifications
| Product Data | |
| Species | Human |
| Expression Host | HEK293T |
| Expression cDNA Clone or AA Sequence |
Recombinant protein was produced with TrueORF clone, RC216151. Click on the TrueORF clone link to view cDNA and protein sequences.
|
| Tag | C-Myc/DDK |
| Predicted MW | 24 kDa |
| Concentration | >50 ug/mL as determined by microplate BCA method |
| Purity | > 80% as determined by SDS-PAGE and Coomassie blue staining |
| Buffer | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol |
| Bioactivity | Binding assay (PMID: 27780863) |
| Preparation | Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps. |
| Storage | Store at -80°C. |
| Stability | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
| Reference Data | |
| RefSeq | NP_000542 |
| Locus ID | 7428 |
| UniProt ID | P40337, A0A024R2F2 |
| Cytogenetics | 3p25.3 |
| Refseq Size | 2968 |
| Refseq ORF | 639 |
| Synonyms | HRCA1; pVHL; RCA1; VHL1 |
| Summary | 'Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]' |
| Protein Families | Druggable Genome, Transcription Factors |
| Protein Pathways | Pathways in cancer, Renal cell carcinoma, Ubiquitin mediated proteolysis |
Documents
| FAQs |
| SDS |
Resources
Recombinant Protein Resources |
Other Versions
| SKU | Description | Size | Price |
|---|---|---|---|
| LC400188 | VHL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LC404985 | VHL HEK293T cell transient overexpression lysate (as WB positive control) |
USD 121.00 |
|
| LY400188 | Transient overexpression lysate of von Hippel-Lindau tumor suppressor (VHL), transcript variant 1 |
USD 436.00 |
|
| LY404985 | Transient overexpression lysate of von Hippel-Lindau tumor suppressor (VHL), transcript variant 2 |
USD 436.00 |
|
| PH316151 | VHL MS Standard C13 and N15-labeled recombinant protein (NP_000542) |
USD 2,055.00 |
|
| TP760451 | Purified recombinant protein of Human von Hippel-Lindau tumor suppressor (VHL), transcript variant 1, full length, with N-terminal HIS tag, expressed in E.Coli, 50ug |
USD 215.00 |
{0} Product Review(s)
Be the first one to submit a review
Germany
Japan
United Kingdom
China